Board of Directors
Michael is President of CET, and editor-in-chief of cet.org. He graduated from Columbia University and received his doctoral degree in physiological psychology from Brown University in 1968. He is Professor of Clinical Psychology in Psychiatry at Columbia, and Director of the Comprehensive Chronotherapy Group, a clinical consortium that provides multifactor assessment and treatment by interdisciplinary specialists.
Michael began his career studying how animals react to daily cycles of light and darkness. Later, still sponsored by the National Institute of Mental Health, he studied the antidepressant, and physiological, effects of light therapy in several hundred patients.
This work led to a set of new non-drug therapies, including 10,000 lux light, dawn/dusk simulation, and high-density negative air ionization. In 1988, he and Anna Wirz-Justice co-founded the Society for Light Treatment and Biological Rhythms (SLTBR), which he served as President (1991-93). He founded CET in 1994.
Michael chaired the Task Force on Light Treatment for Sleep Disorders (American Academy of Sleep Medicine and SLTBR), and served for 12 years on the editorial board of the Journal of Biological Rhythms. In a 40-year collaboration with his wife, Jiuan Su, the Terman lab produced more than 200 scientific publications.
Michael’s dream is that through CET, he will be able to popularize the use of light, and air, to help people with problems of mood, and sleep. In addition, he would like to further research on circadian rhythms, and their role in health, by bringing together stakeholders from a variety of disciplines and vantage points. Please help further these goals by making a contribution to CET!
Dr. John Gottlieb received his undergraduate degree from Oberlin College, attended medical school at the University of Illinois at Chicago, and completed a residency in psychiatry at Yale University in New Haven, Connecticut.
He is an Assistant Professor of Psychiatry at the Feinberg School of Medicine of Northwestern University in Chicago, Illinois. In his university position, John has been actively involved in residency education and supervision. In this role, he developed and teaches one of the first courses in psychiatric chronotherapy in the United States.
In addition, he is the Medical Director of Chicago Psychiatry Associates, a group practice specializing in the evaluation and treatment of cyclic mood disorders. He is a member of the Training and Curriculum Committee of the International Society for Bipolar Disorders.
John’s clinical focus on bipolar disorders led to his interest in both the circadian underpinnings of affective disturbances and the use of biological rhythm-modifying interventions to treat these conditions. He regularly uses bright light therapy, dawn simulation, wake therapy, and darkness therapy.
John’s current research focus is on circadian phase variation in bipolar illness and the use of darkness therapy for manic symptoms.
Paul Kallmes, our technical advisor, consults with CET on technology and product research and development. He has held numerous positions with prominent companies in the lighting industry, including Color Kinetics and Lighting Science Group; he has also advised many other lighting companies on their intellectual property and product development strategies. He is currently raising a venture fund to drive the growth of young companies in the biotech, security, wearables, and cosmetics spaces. Paul serves on the boards of two non-profits: one based in San Francisco that concentrates on technology and education, and one focusing on teaching low-cost, high-volume, quality eye surgery to Chinese ophthalmologists.
Klaus Martiny, MD, DMSc, PhD, Specialist in Psychiatry, is a clinical professor at the University of Copenhagen. He works clinically as head of an intensive affective disorder’s unit at the Mental Health Center Copenhagen, and as a researcher within his New Interventions in Depression Group (NID-Group), at the University of Copenhagen. His main research interest has been focused on augmentation strategies as add-ons to psychopharmacologic treatment for depression primarily within the chronotherapeutic area. His studies have included the use of bright light therapy, dynamic light systems, pindolol, weak electromagnetic fields, wake therapy, sleep time stabilization and exercise.
Dr. Dan Oren received the MD degree from the Yale School of Medicine, where he later did his training in psychiatry and served as an Associate Professor of Psychiatry. He is Medical Director at BHcare in Ansonia, Connecticut, USA.
Dan’s research and clinical interests grew out of a research fellowship in the Clinical Psychobiology Branch of the US National Institute of Mental Health (NIMH) where he worked under the guidance of Drs. Thomas Wehr and Norman Rosenthal, two of the pioneer generation of researchers in the rediscovery and classification of Seasonal Affective Disorder and the establishment of light therapy as a treatment for depression.
His interests include seasonal, atypical, chronic and resistant depression, clinical psychopharmacology, light therapy, sleep disorders and circadian rhythm disturbances. He has written numerous scientific articles and book chapters, and is lead author of How to Beat Jet Lag: A Practical Guide for Air Travelers. His research passion is understanding the molecular mechanism of light therapy for treatment of depression and regulation of biological rhythms, for which he proposed a model of “humoral phototransduction” to explain these phenomena on a molecular level.
Dan is a former president of the Society for Light Treatment and Biological Rhythms. Dan serves as Medical Director of CET’s Chronotherapeutics Consultants, formed in 2004 to advise the hospital and managed care industries on the implementation of light and wake therapies as adjuncts to drug treatment of major depression.
Marylou Selo was born in Bolivia, grew up in Holland and studied in Geneva, Switzerland, and at Georgetown University in Washington, D.C. There she obtained her Diploma as Conference Interpreter and Translator for Dutch, German, English, French, and Spanish. Since 1963, her main home has been New York City.
Marylou was diagnosed with bipolar disorder in 1976, and told she would never work again. Despite this dire prognosis, she quickly resumed her career as a freelance interpreter. She also became a patient advocate in the United States and Europe. She is a co-founder of the Mood Disorder Support Group of New York, Inc, and of the national DBSA (Depression and Bipolar Support Alliance, then known as the National Depressive and Manic Depressive Association). She served as a Board Member of both organizations.
Following the suicide of her father in 1993, Marylou became active in suicide prevention and the destigmatization of mental illness. She served as a Board Member of BBRF (Brain and Behavior Research Foundation), previously NARSAD (National Alliance for Research in Schizophrenia and Affective Disorders), and supported brain research.
In 1994 she founded the Werner Alfred Selo Foundation in Zug, Switzerland, to support research on the comorbidity of depression and headaches. With a group of fellow patients she founded Equilibrium, the Self-Help Organization in Switzerland.
In 2006 Mogens Schou made Marylou the “Poster Child” of IGSLI (International Group for the Study of Lithium), which he had founded to promote the use of lithium.
In 1997 several patient organizations came together in Venice and founded GAMIAN (Global Alliance of Mentally Ill Advocacy Networks). Marylou briefly served as President of GAMIAN-Europe.
Marylou also represents Switzerland at the European Depression Association in Brussels, Belgium. This organization coordinates the activities for European Depression Day (October 1) in all of Europe.
She is a member of the International Bipolar Society and the bipolar societies of Switzerland, Austria and Germany. She advocates for patients’ rights, visits self-help groups, writes for various German newsletters, and lectures at continuing education classes for general practitioners. She also answers e-mail from patients and family members who contact her directly.
Marylou, along with Kay Redfield Jamison, and two other individuals, were featured in a Swiss docudrama, Bipolar ― Life Between Two Extremes. Marylou also appears in Depression: Voices of an Illness, a documentary on depression directed by Bill Liechtenstein.
Anna Wirz-Justice, PhD, is a neurobiologist and emerita Professor at the Centre for Chronobiology, Psychiatric Clinics of the University of Basel.
The Basel clinic was one of the first to extensively study the antidepressant effects of sleep deprivation in the early 70’s. During a fellowship at the US National Institute of Mental Health, she and Thomas Wehr, MD, carried out the first sleep phase advance experiment in a bipolar patient. Anna introduced light therapy to Europe, and followed up with more than 20 years of research on Seasonal Affective Disorder and the psychobiological effects of light. In recent years actimetry studies of rest-activity cycles in psychiatric patients has demonstrated circadian dysregulation in a wide variety of disorders that might be amenable to improvement with light therapy (eg, borderline personality disorder, depression during pregnancy, schizophrenia).
Anna is a former president of the Society for Light Treatment and Biological Rhythms. A prestigious Anna-Monika-Prize with Thomas Wehr recognized their seminal work in the chronobiology of depressive illness. In 2002, she received the Scholar’s Prize of the City of Basel, awarded for outstanding scientific career achievement. In a thematically relevant avocation, she has interacted with architects to enhance the circadian impact of indoor lighting, and the first applications of chronobiological principles are being developed for retirement homes, living quarters for patients with dementia.
Anna is director of CET’s Chronotherapeutics Consultants, formed in 2004 to advise psychiatrists on the implementation of light and wake therapies as adjuncts to drug treatment of major depression. She led a team including Francesco Benedetti and Michael Terman to the field’s first treatment manual for clinicians, Chronotherapeutics for Affective Disorders, now in its second edition. Most recently, together with colleagues, she has been developing courses in chronotherapy to better apply what we know in everyday clinical practice.